|Articles|May 1, 2012
- Pharmaceutical Executive-05-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2012
Marooned at the Top
Advertisement
Articles in this issue
over 14 years ago
Pharma 50 Comment: Seeding Beyond the Baseover 14 years ago
Value-Based Pricing: Too High a Price for UK Pharma?over 14 years ago
Pharm Exec 50: Growth from the Bottom Upover 14 years ago
Country Report: South Africaover 14 years ago
Managing Information Overloadover 14 years ago
Super-Size Me: Optimizing the Information Explosionover 14 years ago
Government: Big Pharma's Best Friend in Emerging Markets?over 14 years ago
Information Overloadover 14 years ago
Pharma's Winning Innovative TechnologyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5